Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Fatty Acyls [FA]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA01090110 16-hydroxy-18-bromo-8E,17E19Z-tricosatrien-4,6-diynoic acid 16-hydroxy-18-bromo-8E,17E19Z-tricosatrien-4,6-diynoic acid C23H31BrO3 434.145656
LMFA01090110 16-hydroxy-18-bromo-8E,17E19Z-tricosatrien-4,6-diynoic acid 16-hydroxy-18-bromo-8E,17E19Z-tricosatrien-4,6-diynoic acid C23H31BrO3 434.145656
LMFA12000151 3E,7Z-Decadien-2-one 3E,7Z-Decadien-2-one C10H16O 152.120115
LMFA07090001 FAHFA 16:0/5O(FA 18:0) 5-hexadecanoyloxy-octadecanoic acid FAHFA 34:0;O C34H66O4 538.496111
LMFA01090047 10-fluoro-capric acid 10-fluoro-decanoic acid C10H19FO2 190.136909
LMFA11000670 1,18-Nonadecadiene 1,18-Nonadecadiene C19H36 264.281701
LMFA01090142 Ethyl (Z) 2,3-diiodoacrylate Ethyl 2,3-diiodo-2Z-propenoate C5H6I2O2 351.845710
LMFA01090142 Ethyl (Z) 2,3-diiodoacrylate Ethyl 2,3-diiodo-2Z-propenoate C5H6I2O2 351.845710
LMFA01090136 Diiodoacetic acid Diiodoethanoic acid C2H2I2O2 311.814409
LMFA11000596 2,3,6-trimethyl-4-Octene 2,3,6-trimethyl-4-Octene C11H22 154.172150
LMFA11000619 5-methylnonane 5-methylnonane C10H22 142.172150
LMFA11000637 trans-1,2-dimethylcyclohexane trans-1,2-dimethylcyclohexane C8H16 112.125200
LMFA11000642 1alpha,3alpha-5alpha-trimethylcyclohexane 1alpha,3alpha-5alpha-trimethylcyclohexane C9H18 126.140850
LMFA11000653 1-methyl-3-isopropylcyclohexane 1-methyl-3-(1-methylethyl)-cyclohexane C10H20 140.156500
LMFA01090059 9,10-dichloro-octadecanoic acid 9,10-dichloro-octadecanoic acid C18H34Cl2O2 352.193587
LMFA01090059 9,10-dichloro-octadecanoic acid 9,10-dichloro-octadecanoic acid C18H34Cl2O2 352.193587
LMFA13030004 3-O-(2-O-(2E-decenoyl)-alpha-L-rhamnopyranosyl)-3-hydroxydecanoic acid 3-O-(2-O-(2E-decenoyl)-alpha-L-rhamnopyranosyl)-3-hydroxydecanoic acid C36H64O10 656.449951
LMFA01050423 2R-hydroxypalmitic acid 2R-hydroxyhexadecanoic acid FA 16:0;O C16H32O3 272.235146
LMFA03020042 10,11-Dihydro-12R-hydroxy-leukotriene E4 (5S,6R,7E,9E,12S,14Z)-6-{[(2S)-2-amino-2-carboxyethyl]sulfanyl}-5,12-dihydroxyicosa-7,9,14-trienoic acid C23H39NO6S 457.249810
LMFA03020042 10,11-Dihydro-12R-hydroxy-leukotriene E4 (5S,6R,7E,9E,12S,14Z)-6-{[(2S)-2-amino-2-carboxyethyl]sulfanyl}-5,12-dihydroxyicosa-7,9,14-trienoic acid C23H39NO6S 457.249810
LMFA03020042 10,11-Dihydro-12R-hydroxy-leukotriene E4 (5S,6R,7E,9E,12S,14Z)-6-{[(2S)-2-amino-2-carboxyethyl]sulfanyl}-5,12-dihydroxyicosa-7,9,14-trienoic acid C23H39NO6S 457.249810
LMFA03020042 10,11-Dihydro-12R-hydroxy-leukotriene E4 (5S,6R,7E,9E,12S,14Z)-6-{[(2S)-2-amino-2-carboxyethyl]sulfanyl}-5,12-dihydroxyicosa-7,9,14-trienoic acid C23H39NO6S 457.249810
LMFA03020044 10,11-dihydro-20-trihydroxy-leukotriene B4 (5R,6Z,8E,12R,14Z)-5,12,20,20,20-pentahydroxyicosa-6,8,14-trienoic acid FA 20:3;O5 C20H34O7 386.230456
LMFA03020044 10,11-dihydro-20-trihydroxy-leukotriene B4 (5R,6Z,8E,12R,14Z)-5,12,20,20,20-pentahydroxyicosa-6,8,14-trienoic acid FA 20:3;O5 C20H34O7 386.230456
LMFA03020044 10,11-dihydro-20-trihydroxy-leukotriene B4 (5R,6Z,8E,12R,14Z)-5,12,20,20,20-pentahydroxyicosa-6,8,14-trienoic acid FA 20:3;O5 C20H34O7 386.230456
LMFA01020395 S-(2-carboxypropyl)-Cysteamine 3-[(2-aminoethyl)sulfanyl]-2-methylpropanoic acid C6H13NO2S 163.066700
LMFA01020395 S-(2-carboxypropyl)-Cysteamine 3-[(2-aminoethyl)sulfanyl]-2-methylpropanoic acid C6H13NO2S 163.066700
LMFA07030009 Type IV cyanolipid 20:1(11Z) ester (1-cyano-2-methylprop-2-en-1-yl) 11Z-eicosenoate C25H43NO2 389.329379
LMFA07030009 Type IV cyanolipid 20:1(11Z) ester (1-cyano-2-methylprop-2-en-1-yl) 11Z-eicosenoate C25H43NO2 389.329379
LMFA07030009 Type IV cyanolipid 20:1(11Z) ester (1-cyano-2-methylprop-2-en-1-yl) 11Z-eicosenoate C25H43NO2 389.329379
LMFA01020040 2,6-dimethyl-pentadecanoic acid 2,6-dimethyl-pentadecanoic acid FA 17:0 C17H34O2 270.255881
LMFA01030927 (2E,4Z)-4-hydroxy-6-oxohexa-2,4-dienoic acid (2E,4Z)-4-hydroxy-6-oxohexa-2,4-dienoic acid FA 6:3;O2 C6H6O4 142.026610
LMFA01030927 (2E,4Z)-4-hydroxy-6-oxohexa-2,4-dienoic acid (2E,4Z)-4-hydroxy-6-oxohexa-2,4-dienoic acid FA 6:3;O2 C6H6O4 142.026610
LMFA08020183 IC202B N-(5-aminopentyl)-N-hydroxy-N'-[5-(hydroxy{4-[(5-nitropentyl)amino]-4-oxobutanoyl}amino)pentyl]butanediamide C23H44N6O8 532.322063
LMFA08020183 IC202B N-(5-aminopentyl)-N-hydroxy-N'-[5-(hydroxy{4-[(5-nitropentyl)amino]-4-oxobutanoyl}amino)pentyl]butanediamide C23H44N6O8 532.322063
LMFA07070053 Butenylcarnitine (3S)-3-[(2E)-but-2-enoyloxy]-4-(trimethylazaniumyl)butanoate CAR 4:1 C11H19NO4 229.131409
LMFA07070053 Butenylcarnitine (3S)-3-[(2E)-but-2-enoyloxy]-4-(trimethylazaniumyl)butanoate CAR 4:1 C11H19NO4 229.131409
LMFA01050457 (R)-3-hydroxy-3-methyl-2-oxopentanoic acid (3R)-3-hydroxy-3-methyl-2-oxopentanoic acid FA 6:1;O2 C6H10O4 146.057910
LMFA01050457 (R)-3-hydroxy-3-methyl-2-oxopentanoic acid (3R)-3-hydroxy-3-methyl-2-oxopentanoic acid FA 6:1;O2 C6H10O4 146.057910
LMFA01050457 (R)-3-hydroxy-3-methyl-2-oxopentanoic acid (3R)-3-hydroxy-3-methyl-2-oxopentanoic acid FA 6:1;O2 C6H10O4 146.057910
LMFA01031015 mediomycin A (2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid C62H97NO18S 1175.642641
LMFA01031015 mediomycin A (2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid C62H97NO18S 1175.642641
LMFA01031015 mediomycin A (2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid C62H97NO18S 1175.642641
LMFA01031015 mediomycin A (2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid C62H97NO18S 1175.642641
LMFA01031015 mediomycin A (2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid C62H97NO18S 1175.642641
LMFA05000543 (2E,4E)-2,4-Decadien-1-ol (2E,4E)-deca-2,4-dien-1-ol FOH 10:2 C10H18O 154.135765
LMFA07010991 Pentyl heptanoate pentyl heptanoate WE 12:0 C12H24O2 200.177630
LMFA12000174 7Z-Tetradecen-2-one 7Z-Tetradecen-2-one C14H26O 210.198365
LMFA04010348 ent-7-epi-14-E4c-NeuroP (Z)-6-((1R,2R,3S)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid FA 22:6;O3 C22H32O5 376.224976
LMFA01050619 Maoleiferacid A 9R,10S-dihydroxy-tetradeca-7E-en-5-ynoic acid FA 14:3;O2 C14H22O4 254.151810